These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5826083)

  • 1. Cyclophosphamide in the treatment of malignant diseases.
    Kini PM; Sivakumar S; Pai KN
    J Indian Med Assoc; 1965 Aug; 45(4):195-200. PubMed ID: 5826083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclophosphamide therapy in malignant diseases. Experience from a 10 year period in a medical department].
    Laursen ML
    Ugeskr Laeger; 1972 Feb; 134(6):269-73. PubMed ID: 5010245
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive cyclophosphamide therapy in advanced malignant disease.
    Binns JH; Southall AC
    Practitioner; 1970 Apr; 204(222):546-8. PubMed ID: 5443539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apropos of the treatment of malignant tumors by continuous endolymphatic chemotherapy].
    Thépot J
    Mem Acad Chir (Paris); 1965 Jun 9-16; 91(19):607-16. PubMed ID: 4284307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of advanced malignant neoplasms with cyclophosphamide An evaluation].
    Singer Z; Rozek-Lesiak K; Swierczyńska B
    Wiad Lek; 1976 Jun; 29(12):1085-91. PubMed ID: 951984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic chemotherapy in the treatment of malignant tumors].
    Langhammer H; Klemm J; Pabst HW
    Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences in the use of cyclphosphamide (Endoxan)].
    Aksoycan S; Tauschwitz K
    Med Welt; 1965 Jun; 26():1450-4. PubMed ID: 5318700
    [No Abstract]   [Full Text] [Related]  

  • 8. The course of nausea and vomiting after high-dose cyclophosphamide.
    Fetting JH; Grochow LB; Folstein MF; Ettinger DS; Colvin M
    Cancer Treat Rep; 1982 Jul; 66(7):1487-93. PubMed ID: 7093965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide and 5-fluoracil in the treatment of inoperable tumors].
    Engell HC; Ulrich K
    Ugeskr Laeger; 1966 Mar; 128(11):325-9. PubMed ID: 5915749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with alkylating substances in the treatment of malignant primary and secondary skeletal tumors].
    Löhr E
    Zentralbl Chir; 1966 Aug; 91(33):1197-204. PubMed ID: 5995386
    [No Abstract]   [Full Text] [Related]  

  • 11. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of pain in patients with inoperable tumors, using xylocaine and cyclophosphamide of nitrogen mustard].
    Caminiti G
    Minerva Anestesiol; 1966 Jan; 32(1):57. PubMed ID: 4160106
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the prognosis and therapy of malignant testicular tumors].
    Köhler K; Platzbecker H
    Z Urol Nephrol; 1966 Mar; 59(3):213-7. PubMed ID: 5984153
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Longterm intra-arterial infusion in the treatment of malignant tumors].
    Vojtísek V; Lorenc J; Topol O; Abrahamovic M; Jelínek V
    Rozhl Chir; 1966 Feb; 45(2):140-6. PubMed ID: 5913623
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of cyclophosphamide in antineoplastic therapy].
    Cugini A; Sosso A
    Minerva Med; 1966 May; 57(42):1914-21. PubMed ID: 5949443
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone).
    Mandelli F; Biagini C; Baroni CD; Bosman C; Anselmo AP; de Luca AM; Granati L; Petti N; Papa G
    Haematologica; 1980 Feb; 65(1):107-18. PubMed ID: 6768646
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide in vitiligo.
    Gokhale BB; Parakh AP
    Indian J Dermatol; 1983 Jan; 28(1):7-10. PubMed ID: 6852882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.